Perfil
Stephane Depil served as the Chief Executive Officer of NETRIS Pharma SAS and as the Medical Director of the Cancer Immunotherapy Program at Centre Léon Bérard Lyon et Rhône-Alpes.
He also worked as the Chief Medical Officer and EVP-Research & Development at Cellectis SA from 2017 to 2019.
Depil holds a doctorate degree from Université de Lille III.
Antiguos cargos conocidos de Stephane Depil.
| Empresas | Cargo | Fin |
|---|---|---|
| CELLECTIS S.A. | Chief Tech/Sci/R&D Officer | 01/02/2019 |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Chief Executive Officer | - |
| Centre Léon Bérard Lyon et Rhône-Alpes | Corporate Officer/Principal | - |
Formación de Stephane Depil.
| Université de Lille III | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| Empresas privadas | 2 |
|---|---|
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Health Technology |
| Centre Léon Bérard Lyon et Rhône-Alpes |
- Bolsa de valores
- Insiders
- Stephane Depil
